The Reality of Rolling Out Covid-19 Vaccines

June 21, 2021

The latest phase of the Covid-19 pandemic response has exposed a wide chasm between high-income and lower-income countries, as some states race ahead in their Covid-19 vaccination campaigns while others have yet to begin. As the global vaccination effort contends with supply shocks and geopolitical challenges, national health leaders must confront a reality of scarce resources, surging caseloads in some areas, and pandemic fatigue. How have lower- and lower-middle income countries approached this unprecedented immunization campaign, and what are the prospects for the next phase of the rollout as supply is scaled up? How can the needs and challenges lower- and lower-middle income countries are facing be better addressed in efforts to achieve more equitable distribution of Covid-19 vaccines?

Please join the CSIS Commission on Strengthening America’s Health Security on Monday, June 21 from 10:00 a.m. to 11:00 a.m. EDT for an online event focused on lower- and lower-middle income country experiences preparing for and delivering Covid-19 vaccines. The event will begin with keynote remarks from Henrietta Fore, Executive Director of UNICEF, who will be introduced by John J. Hamre, CSIS President, CEO, and Langone Chair in American Leadership. Ms. Fore will then be joined by a panel of international experts including Charles Akataobi, Epidemiologist/Field Coordinator with the African Field Epidemiology Network (AFENET), Nigeria; Martha Ngoe, Bureau Chief for International Vaccination and Travel Medicine and Sub-National Surveillance Officer, South-West Region, Ministry of Public Health, Cameroon; and Shyam Raj Upreti, Coordinator of the COVID-19 Vaccine Expert Advisory Committee in the Ministry of Health and Population, Nepal, who will discuss their countries’ current efforts in rolling out Covid-19 vaccines in a conversation moderated by CSIS Global Health Policy Center Senior Fellow Katherine E. Bliss.

You May Also Like

Linked Webinar on One-dose HPV vaccination: Evidence, lessons learned and strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and alleviate delivery challenges such as those encountered during the COVID-19 pandemic. Whether countries are in the initial stages of introducing the HPV vaccine or considering a switch, they … Read More

How to leverage market intelligence, including demand and country-specific disease information, for national decision-making and product choice

The Vaccine Procurement Practitioners Network (VPPN) invites you to their second webinar of a 3-part series, which will be held on Thursday, 19 September 2024, from 10am to 10.45am GMT+2, in English, Russian and French. Covering how market intelligence can be leveraged for national decision-making and vaccine product choice, this webinar will feature Procurement Service Manager … Read More

Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy part 2

This is the second webinar of a 3-part series, which will be held on Thursday, 19 September 2024, from 10am to 10.45am GMT+2, in English, Russian and French. Covering how market intelligence can be leveraged for national decision-making and vaccine product choice, this webinar will feature Procurement Service Manager Eveli Bauer, from the Health Insurance … Read More